Articles

What makes an effective communications plan?

1st September 2014

What makes an effective communications plan?Lea Studer

A communications plan gives focus and structure to the numerous aspects of a company's communications. This article examines the elements of an effective communications plan and how best to implement... Read more

Performance coaching - the leadership style that time forgot

29th August 2014

Performance coaching - the leadership style that time forgot Nikki Burgess, Maureen Deehan & Allan Mackintosh

Speakers at recent sales force effectiveness (SFE) conferences have highlighted the importance of line managers coaching sales teams in the field and supporting them with personal development. In a market... Read more

Cancer Drugs Fund budget increased – but pharma prices to be challenge…

28th August 2014

Cancer Drugs Fund budget increased – but pharma prices to be challengedAndrew McConaghie

England's Cancer Drugs Fund is to see its annual budget increased by 40 per cent – but 'excessively priced' drugs could be removed from the list if companies refuse to... Read more

The Game Changer – 3D in Healthcare Apps

28th August 2014

The Game Changer – 3D in Healthcare AppsAshish Khera

Are healthcare apps really changing the healthcare landscape? Ashish Khera discusses the trends, the extent to which apps are affecting the industry and the use of 3D in anatomy-related medical... Read more

News

Hits and misses highlighted at ESC heart congress

1st September 2014

Hits and misses highlighted at ESC heart congressStaff Reporter

The news from the European Society of Cardiology (ESC) meeting in Barcelona is currently being dominated by Novartis' LCZ696 and Sanofi/Regeneron's alirocumab, but there is a lot more going on... Read more

Sanofi and Regeneron push positive results for PCSK9 inhibitor

1st September 2014

Sanofi and Regeneron push positive results for PCSK9 inhibitor Linda Banks

Sanofi and Regeneron have announced positive results from trials of novel drug alirocumab, which targets PCSK9, in people with hypercholesterolemia.The results of the four phase III ODYSSEY trials were showcased... Read more

Novartis drug could be breakthrough in heart failure

1st September 2014

Novartis drug could be breakthrough in heart failureAndrew McConaghie

A new treatment, LCZ696, has produced exceptionally impressive results in cutting risk of death in heart failure patients, and has been heralded as a major breakthrough in the condition.The potential... Read more

Ice bucket challenge tally nears $100m

29th August 2014

Ice bucket challenge tally nears $100mStaff Reporter

The ALS Ice Bucket Challenge has raised a staggering $94.3 million for the motor neurone disease (MND) charity behind the initiative, but has left it wondering where to spend the... Read more

Audio & Video

Tweetchat: Managing diabetes in the real…

Atlantis Healthcare diabetes Tweetchat


Atlantis Health is working with pharmaphorum to conduct a Tweetchat on the real world challenges patients face in managing... View more

Patient Opinion Leaders: Andrew Schorr

 

As a cancer survivor and passionate patient advocate, Andrew Schorr typifies the concept of a Patient Opinion Leader (POL). He is a contributor to the... View more

View the recorded webinar - The future o…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

Rare Disease Day tweetchat

 

To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

Amgen submits BLA to FDA for novel cholesterol drug

Amgen has submitted the first Biologics Licence Application (BLA) to the US FDA for a PCSK9 inhibitor.<... Read more

News

BMS hep C drug approved in Europe

The news in hepatitis C in recent months has all been about Gilead's record-smashing launch of Sovaldi and wh... Read more

News

NICE wants more cost evidence on BI’s diabetes drug

More evidence on the cost-effectiveness of Boehringer Ingelheim's type 2 diabetes drug empagliflozin has been re... Read more

News

StemCells turning a corner?

The path seems to be clearing in front of US biotech StemCells as it advances cell-based therapies for blindness... Read more

News

The case for one global SOP for medical publications

As medical publishing becomes increasingly global, it makes sense to institute one standard operating procedure to m... Read more

Articles

ViiV gets US approval for Atripla rival Triumeq

Armed with FDA approval for its triple HIV drug Triumeq, ViiV Healthcare can now start to challenge rival Gil... Read more

News